Healthcare 24 May 2026 - 2 June 2026

Option Care Health Shares Edge Higher, Market Focuses on Outlook
····

Option Care Health Shares Edge Higher, Market Focuses on Outlook

Option Care Health ticked just above flat Tuesday afternoon after the home-infusion provider said it was ranked No. 15 on TIME’s 2026 list of the world’s most impactful companies. The stock traded 0.1% higher at $20.49, volume near 528,000 shares. It moved between $20.21 and $20.64. The QQQ ETF, which tracks the Nasdaq, gained 0.4%. Health Care Select Sector SPDR Fund, which covers the sector, slipped 1.1%.
June 2, 2026
Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan
····

Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan

Mobia Medical shares traded lower on Monday morning, as the stroke-recovery device maker stayed under its IPO price less than a month after listing on the Nasdaq. The stock last traded at $12.84, off 26 cents from Friday’s close. It moved between $12.71 and $13.32 earlier in the session. Mobia is in its first run as a public company. The IPO put 10 million shares on sale at $15 apiece and aimed to bring in roughly $150 million before fees and other costs.
June 1, 2026
Rezolute Shares Edge Higher Ahead of Key FDA Week
····

Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute Inc. shares ticked up in premarket trading Monday, with the gain coming ahead of a scheduled appearance by company executives at a healthcare event later this week. The shares were at $3.30, up 4 cents, with the rare-disease drug maker’s market cap around $343 million. This was before the regular Nasdaq open; the exchange lists pre-market hours from 4:00 a.m. to 9:30 a.m. Eastern.
June 1, 2026
Aveanna Healthcare draws attention after debt repricing and Friday dip
····

Aveanna Healthcare draws attention after debt repricing and Friday dip

Aveanna Healthcare Holdings Inc. shares are back in focus as premarket action opens Monday, following a down day Friday. Investors are watching a standard shareholder vote, recent debt repricing, and an investor presentation set for Tuesday. Aveanna finished at $7.17 on May 29, a drop of 2.18%, based on its historical pricing chart. Timing is key here. Nasdaq’s premarket was active at the dateline, but normal hours are 9:30 a.m. to 4:00 p.m. Eastern. June 1 isn’t marked on Nasdaq’s 2026 U.S. holiday list.
June 1, 2026
Lyell Quiet as Bigger CAR-T Question Lingers for Investors
····

Lyell Quiet as Bigger CAR-T Question Lingers for Investors

Lyell Immunopharma stock posted a late rebound to close out the short week, gaining almost 3% to finish at $17.33 on Friday. Shares moved in a $16.30 to $17.475 range, according to Investing.com. The cancer cell-therapy name lagged the broader U.S. market. Lyell is still trading as a clinical-readout story, not on earnings. Its value depends on whether its main CAR T-cell drug, ronde-cel, can deliver enough on safety and efficacy to compete with approved therapies for large B-cell lymphoma.
May 31, 2026
MediWound Shares Slide This Week; BARDA Moves in Focus
····

MediWound Shares Slide This Week; BARDA Moves in Focus

MediWound Ltd. closed Friday at $14.33, off 1.6% for the day and down about 13.6% since May 22. The market cut its outlook for the wound-care drug company’s near-term revenue. Shares slid hardest on Wednesday, dropping 14.1% on 451,100 shares traded. MediWound shares moved lower even as the Nasdaq Composite finished higher on Friday, ending its best two-month run in over 20 years. The selloff stands out, pointing to questions around the company and not a broad biotech slump.
May 30, 2026
Definitive Healthcare Stock Jumps, With Traders Watching the $1 Level
····

Definitive Healthcare Stock Jumps, With Traders Watching the $1 Level

Definitive Healthcare Corp. finished the holiday-shortened week up, gaining 4.88% Friday to settle at $0.93. The healthcare data company is still trading below the $1 level, which has been a key line for the stock. About 574,000 shares changed hands, with trading in a range from $0.84 to $0.97. Rebound timing is in focus this week as U.S. markets were closed over the weekend and again on Monday, May 25, for Memorial Day. That gives investors just a few days to figure out if the bounce lasts. Nasdaq notes that normal hours are Monday to Friday, 9:30 a.m. to 4 p.m. ET.
May 30, 2026
Orchestra BioMed Shares Trade Lower Ahead of Trial Milestone
····

Orchestra BioMed Shares Trade Lower Ahead of Trial Milestone

Orchestra BioMed Holdings shares fell in Friday afternoon trade. Investors seemed to look ahead to upcoming milestones for its Medtronic-partnered hypertension therapy, while the news flow stayed quiet. The stock traded lower, falling 0.8% to $3.95 as roughly 116,000 shares changed hands. The move trailed the broader biotech sector, where the SPDR S&P Biotech ETF added 0.4%, but the iShares Nasdaq Biotechnology ETF slipped 0.2%.
May 29, 2026
Eva Live Stock Falls As $20 Million AI Senior-Care Bet Runs Into Cash Questions
····

Eva Live Stock Falls As $20 Million AI Senior-Care Bet Runs Into Cash Questions

Eva Live Inc. shares fell in early Nasdaq trading on Friday, giving back part of this week’s move after the AI advertising company filed a plan to push into senior-care technology through a proposed investment of up to $20 million. The stock was recently at $3.275, down 11.5 cents from its previous close, after trading between $3.15 and $3.39. Volume was 43,221 shares, and the company’s market value stood near $118 million.
May 29, 2026
Pliant Therapeutics Rises $1.25 Ahead of ASCO Conference
····

Pliant Therapeutics Rises $1.25 Ahead of ASCO Conference

Pliant Therapeutics Inc. moved up in late trading Thursday, last seen at $1.25, up roughly 1.2% from the previous close. Market cap hovered around $77 million. Volume was a bit over 210,000 shares. The move came once the regular Nasdaq session closed. Nasdaq’s regular hours are 9:30 a.m. to 4 p.m. ET, then after-hours trading goes till 8 p.m. ET. After-hours is any trading after the main session, usually with less liquidity.
May 29, 2026
MapLight Stock Slips Ahead of August Drug Update
···

MapLight Stock Slips Ahead of August Drug Update

MapLight Therapeutics shares slipped Thursday. New Wall Street research coverage still pointed to the company’s clinical-trial results coming in mid-August, which investors say is the next key test for a stock that’s traded far above its IPO level. The stock traded at $29.17, down 1.3%. The SPDR S&P Biotech ETF added 0.8%, while iShares Nasdaq Biotechnology ETF climbed 1.1%. MapLight carried a market cap close to $1.32 billion. Shares changed hands between $28.72 and $30.33 during the session.
May 28, 2026
Maze Therapeutics Heads for June With Wall Street Watching Kidney Drug
····

Maze Therapeutics Heads for June With Wall Street Watching Kidney Drug

Maze Therapeutics stock was little changed in Thursday’s premarket trade as investors shrugged off a sparse update from the company. Focus is already shifting to June, when investor events could provide more detail on Maze’s main kidney-disease program. The stock fell about 1.2% to $26.05 in recent trade, leaving the South San Francisco biotech's market value near $1.4 billion. Biotech shares elsewhere traded higher. The SPDR S&P Biotech ETF was up 0.8%. The iShares Nasdaq Biotechnology ETF added 0.3%.
May 28, 2026
Quantum X Labs Shares Edge Up After New CliniQuantum Info as Markets Wait on Cash Update
····

Quantum X Labs Shares Edge Up After New CliniQuantum Info as Markets Wait on Cash Update

Quantum X Labs Inc. shares moved higher Wednesday. Investors responded to new details about a CliniQuantum transaction involving the company’s quantum technology portfolio. The Nasdaq-listed company also named a new scientific adviser. The stock last traded at $4.26, up 11 cents on the day, after moving between $4.14 and $4.35. Just 27,676 shares changed hands, a reminder of how thinly traded this small-cap remains.
May 27, 2026
This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade
····

This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade

enVVeno Medical Corp. shares were last available at $11.25 before regular Nasdaq trading on Wednesday, up 18 cents from the prior close, giving the Irvine, California-based medical-device developer a market value of about $7.4 million. It is a small stock, so a modest price move can carry more noise than signal. The timing matters. Nasdaq’s regular market runs from 9:30 a.m. to 4 p.m. Eastern, and U.S. equity markets had just come through Monday’s Memorial Day closure; Wednesday was set up as a normal trading day, not a holiday tape.
May 27, 2026
Sanara MedTech Dips After Swing to Profit
····

Sanara MedTech Dips After Swing to Profit

Sanara MedTech Inc. traded lower Tuesday, even as the broader U.S. market moved up. The stock was at $22.69 at 10:38 a.m. EDT, down 48 cents since Friday’s close. Around 4,010 shares changed hands. Investors are still looking at the company’s latest swing to profit and weighing its spending plans. Market hours are in focus as U.S. equity trading resumed after Memorial Day. Nasdaq’s calendar listed May 25 as a holiday, with normal trading from 9:30 a.m. to 4 p.m. Eastern.
May 26, 2026
Gilead Stock Gets FDA Nod, But Investors Face Hurdle
····

Gilead Stock Gets FDA Nod, But Investors Face Hurdle

Gilead Sciences will get its first U.S. session move on Hepcludex Tuesday, after winning FDA approval as the first chronic hepatitis delta virus treatment. The stock was last at $134.36, with markets shut Monday for Memorial Day. Timing is key here. Gilead is working to show growth outside its main HIV business as it leans on new liver-disease and cancer drugs to make up for shrinking sales in older drugs and costs from recent acquisitions.
May 26, 2026
Tandem Diabetes Shares Dropped Friday as Market Watched for Next Week’s Move
····

Tandem Diabetes Shares Dropped Friday as Market Watched for Next Week’s Move

Tandem Diabetes Care closed down around 5% to $14.96 on Friday, ahead of the long Memorial Day weekend. The insulin-pump maker’s shares ended the session lower as Nasdaq will be closed through Monday. Tandem shares had bounced going into the end of the week. The LSEG-based lookup had TNDM finishing at $13.53 on Monday, $15.76 on Thursday, then slipping to $14.96 at Friday's close. That's still a gain of roughly 10.6% from where it started, despite giving up ground late in the week.
May 24, 2026
Ribbon’s stock muted ahead of holiday; eyes on DRC medicine deal instead
····

Ribbon’s stock muted ahead of holiday; eyes on DRC medicine deal instead

Ribbon Acquisition Corp.’s Class A shares on Nasdaq closed flat heading into the long U.S. weekend, as traders looked ahead to see how much cash and backing the SPAC will keep for its planned merger with Japan’s DRC Medicine. Ribbon is set up as a special purpose acquisition company, or SPAC, meant to merge with a private firm and take it public. There won’t be any regular U.S. stock trading Monday, with Nasdaq showing Memorial Day—May 25, 2026—as a market holiday. That means the next time investors can trade Ribbon’s securities is Tuesday.
May 24, 2026
Dentsply Sirona stock lifts after holiday weekend, but turnaround questions remain
····

Dentsply Sirona stock lifts after holiday weekend, but turnaround questions remain

• Dentsply Sirona finished Friday at $10.21, a gain of 2.8% for the session and up around 1.4% versus last Friday.• The U.S. markets are closed for the weekend, and Nasdaq will be closed Monday for Memorial Day.• The next planned update from the company is at Stifel’s Jaws & Paws conference on Wednesday. Dentsply Sirona Inc. shares picked up late in the week, handing investors a modest gain ahead of the U.S. holiday and an upcoming management presentation seen as a possible test for the dental-products company’s turnaround story.
May 24, 2026
1 2 3 … 6